Sean Maduck
2021
In 2021, Sean Maduck earned a total compensation of $4.5M as Chief Commercial Officer at Corcept Therapeutics, a 42% increase compared to previous year.
Compensation breakdown
| Bonus | $309,375 |
|---|---|
| Option Awards | $3,716,355 |
| Salary | $519,451 |
| Total | $4,545,181 |
Maduck received $3.7M in option awards, accounting for 82% of the total pay in 2021.
Maduck also received $309.4K in bonus and $519.5K in salary.
Rankings
In 2021, Sean Maduck's compensation ranked 2,918th out of 12,415 executives tracked by ExecPay. In other words, Maduck earned more than 76.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,918 out of 12,415 | 77th |
Division Manufacturing | 1,164 out of 5,505 | 79th |
Major group Chemicals And Allied Products | 463 out of 2,375 | 81st |
Industry group Drugs | 406 out of 2,096 | 81st |
Industry Pharmaceutical Preparations | 273 out of 1,546 | 82nd |
Source: SEC filing on April 25, 2022.
Maduck's colleagues
We found four more compensation records of executives who worked with Sean Maduck at Corcept Therapeutics in 2021.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019